Patent US6989243B2 successfully refreshed from Google Patents.
← Back to Patent Explorer
US6989243B2 Expired / Lapsed US ⏱️ 0.0 years remaining

Method of determining the concentration of an analyte in a physiological sample

Assignee: Cilag GmbH International
•
Filing: 2002-05-24
•
Granted: 2006-01-24
•
Expires: 2022-05-24
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Methods for determining the concentration of an analyte, e.g. glucose, in a physiological sample, are provided. The subject methods use reagent test strips which include one or more members of an analyte oxidation signal producing system and at least one hemolyzing agent. The subject methods are particularly suited for use in the detection of blood glucose concentrations.

Inventors

  • 👤 Adva Yani
  • 👤 Paing C. Huang

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-05 00:40
CPC Classifications
C; C12; C12Q; C12Q1/00; C12Q1/26; C12Q1/28; C12Q1/54; G; G01; G01N; G01N33/00; G01N33/48; G01N33/50; G01N33/52; G01N33/521; Y; Y10; Y10S; Y10S435/00; Y10S435/975

Claims Analysis

Total Claims: 6
Claim 1
Independent Claim 111 words
A method of determining a analyte concentration in a physiological sample, said method comprising: (a) applying said physiological sample to a test strip comprising: (i) a porous matrix; (ii) at least one member of an analyte oxidation signal producing system; and (iii) at least one hemolyzing agent, wherein said hemolyzing agent is present in an amount sufficient to produce hemolysis which is equivalent to a hemolysate concentration in a physiological sample applied to said porous matrix in an amount ranging from about 5 to 20% by volume; (b) detecting a signal produced by said signal producing system; and (c) relating said detected signal to the analyte concentration in said physiological sample.
Claim 2
Independent Claim 111 words
A method of determining a analyte concentration in a physiological sample, said method comprising: (a) applying said physiological sample to a test strip comprising: (i) a porous matrix; (ii) at least one member of an analyte oxidation signal producing system; and (iii) at least one hemolyzing agent, wherein said hemolyzing agent is present in an amount sufficient to produce hemolysis which is equivalent to a hemolysate concentration in a physiological sample applied to said porous matrix in an amount ranging from about 5 to 20% by volume; (b) detecting a signal produced by said signal producing system; and (c) relating said detected signal to the analyte concentration in said physiological sample.
Claim 3
Dependent Claim 12 words
The method according to claim 1 , wherein said analyte is glucose.
Claim 4
Dependent Claim 14 words
The method according to claim 1 , wherein said physiological sample is whole blood.
Claim 5
Dependent Claim 47 words
The method according to claim 1 , wherein said hemolyzing agent is present in an amount sufficient to produce hemolysis which is equivalent to the hemolysate concentration in a physiological sample applied to said porous matrix in an amount ranging from about 5 to 20% by volume.
Claim 6
Dependent Claim 20 words
The method according to claim 1 , wherein said detecting and relating steps are carried out by an automated instrument.

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 2009-01-23 2009-07-25 2010-01-24 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 2013-01-23 2013-07-25 2014-01-24 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2017-01-23 2017-07-25 2018-01-24 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag